- Home
- CNTB vs CSBR Comparison
CNTB vs CSBR Comparison
Compare CNTB & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTB
- CSBR
- Stock Information
- Founded
- CNTB 2012
- CSBR 1985
- Country
- CNTB United States
- CSBR United States
- Employees
- CNTB N/A
- CSBR N/A
- Industry
- CNTB Biotechnology: Pharmaceutical Preparations
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CNTB Health Care
- CSBR Health Care
- Exchange
- CNTB Nasdaq
- CSBR Nasdaq
- Market Cap
- CNTB 65.5M
- CSBR 65.9M
- IPO Year
- CNTB 2021
- CSBR 1986
- Fundamental
- Price
- CNTB $1.11
- CSBR $4.50
- Analyst Decision
- CNTB Strong Buy
- CSBR Strong Buy
- Analyst Count
- CNTB 1
- CSBR 1
- Target Price
- CNTB $8.00
- CSBR $6.00
- AVG Volume (30 Days)
- CNTB 28.8K
- CSBR 11.7K
- Earning Date
- CNTB 09-05-2024
- CSBR 12-10-2024
- Dividend Yield
- CNTB N/A
- CSBR N/A
- EPS Growth
- CNTB N/A
- CSBR N/A
- EPS
- CNTB N/A
- CSBR N/A
- Revenue
- CNTB $24,116,000.00
- CSBR $51,655,000.00
- Revenue This Year
- CNTB N/A
- CSBR $9.27
- Revenue Next Year
- CNTB $63.90
- CSBR $9.76
- P/E Ratio
- CNTB N/A
- CSBR N/A
- Revenue Growth
- CNTB N/A
- CSBR N/A
- 52 Week Low
- CNTB $0.68
- CSBR $3.60
- 52 Week High
- CNTB $2.84
- CSBR $7.13
- Technical
- Relative Strength Index (RSI)
- CNTB 45.31
- CSBR 54.07
- Support Level
- CNTB $0.98
- CSBR $4.30
- Resistance Level
- CNTB $1.09
- CSBR $4.70
- Average True Range (ATR)
- CNTB 0.10
- CSBR 0.24
- MACD
- CNTB -0.01
- CSBR 0.06
- Stochastic Oscillator
- CNTB 31.28
- CSBR 78.95
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.